Investigation Report on China Tacrolimus Market, 2010-2019

Publisher Name :
Date: 11-Jun-2015
No. of pages: 30

Description

Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus acts like cyclosporine and its systemic use is mainly for the prevention of allograft rejection and the treatment of immune disease. Different from cyclosporine, it can penetrate through epidermis barrier due to its relatively small molecular mass. Therefore to avoid systemic adverse reactions, it can be made into external preparation to treat various immune inflammatory cutaneous disorders.

After entering China in 1999, Tacrolimus develops fast with annual sales rising from less than CNY 100 million in 2005 to CNY 688 million in 2014 and CAGR reaching up to 24.7% during this period. Tacrolimus in the Chinese market are in four formulations: injection, capsule, eye drop and ointment, among which the sales value of capsules takes up over 90% of the sum in 2014. Tacrolimus is used for a variety of indications, for example, capsules are mainly used to prevent graft rejection after liver or kidney transplantation.

Tacrolimus in the Chinese market mainly comes from the following companies: Fujisawa Pharmaceutical Co., Ltd (Ireland), Hisun, Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, Sichuan Med-Shine Pharmaceutical Co., Ltd and Astellas Pharma Manufacturing,Inc, among which Fujisawa Pharmaceutical Co., Ltd (Ireland) has the largest market share of 75.40% by sales value in 2014.

As the number of organ transplants and the number of the cases of immune disease increase, the sales value of Tacrolimus in China is expected to keep growing.

Readers can get at least the following information from this report:


  • market share of manufacturers of Tacrolimus in China

  • price of Tacrolimus in Chinese market

  • major manufacturers of Tacrolimus in Chinese market

  • share of dosage forms of Tacrolimus in China

  • market outlook of Tacrolimus in China


The author suggests the following groups of people purchase this report:


  • manufacturers of immunosuppressants

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Investigation Report on China Tacrolimus Market, 2010-2019

Table of Contents

1 Related Concepts of Tacrolimus
1.1 Indication
1.2 Developments in Global Market

2 Market Profile of Tacrolimus in China
2.1 Patent and Approval Status of Tacrolimus in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Value of Tacrolimus in China, 2010-2014
3.1 Overall Sales Value
3.2 Sales Value by Regions

4 Survey on Sales Volume of Tacrolimus in China, 2010-2014
4.1 Overall Sales Volume
4.2 Sales Volume by Regions

5 Survey on Market Share of Major Manufacturers of Tacrolimus in China, 2010-2014
5.1 Market Share by Sales Value
5.2 Market Share by Sales Volume

6 Survey on Market Size of Dosage Forms of Tacrolimus in China, 2010-2014
6.1 Market Share of Different Dosage Forms by Sales Value
6.2 Market Share of Different Dosage Forms by Sales Volume

7 Reference Retail Price of Tacrolimus in China in 2014
7.1 Astellas Pharma Manufacturing,Inc.(US) (Trade Name: Prograf)
7.2 Senju Pharmaceutical Co., Ltd (Japan) (Trade Name: Protopic)
7.3 Sichuan Med-Shine Pharmaceutical Co., Ltd (Trade Name: Ming Zhi Xin)
7.4 Sinopharm Chuankang Pharmaceutical Co., Ltd (Trade Name: Yi Li Kang)
7.5 Yamanouchi Pharmaceutical Co., Ltd (Japan)
7.6 Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
7.7 Zhejiang Hisun Pharmaceutical Co.,Ltd.
7.8 Fujisawa Pharmaceutical Co., Ltd (Ireland) (Trade Name: Prograf)

8 Major Manufacturers of Tacrolimus in the Chinese Market, 2010-2014
8.1 Astellas Pharma Manufacturing,Inc.
8.2 Zhejiang Hisun Pharmaceutical Co.,Ltd.
8.3 Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
8.4 Sichuan Med-Shine Pharmaceutical Co., Ltd
8.5 Yamanouchi Pharmaceutical Co., Ltd (Japan)

9 Market Outlook of Tacrolimus in China, 2014-2018
9.1 Forecast of Market Size
9.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Tacrolimus in China
Chart Approval Information of Tacrolimus in China
Chart Sales Status of Tacrolimus in China, 2010-2014
Chart Sales Value of Tacrolimus in China, 2010-2014
Chart Sales Value of Tacrolimus in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Tacrolimus for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Fujisawa (Ireland) in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Hangzhou Zhongmei Huadong in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Yamanouchi (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Made by Hisun in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Injections in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Eye Drops in China, 2010-2014
Chart Sales Value and Market Share of Tacrolimus Capsules in China, 2010-2014
Chart Price of Tacrolimus Made by Astellas Pharma Manufacturing,Inc.(US) in Some Regions in China
Chart Price of Tacrolimus Made by Senju Pharmaceutical Co., Ltd (Japan) in Some Regions in China
Chart Price of Tacrolimus Made by Yamanouchi Pharmaceutical Co., Ltd (Japan) in Some Regions in China
Chart Price of Tacrolimus Made by Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd in Some Regions in China
Chart Price of Tacrolimus Made by Hisun in Some Regions in China
Chart Price of Tacrolimus Made by Fujisawa Pharmaceutical Co., Ltd (Ireland) in Some Regions in China

  • Global Systemic Lupus Erythematosus (Sle) Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Systemic Lupus Erythematosus (Sle) Drugs market: According to our latest research, the global Systemic Lupus Erythematosus (Sle) Drugs market looks promising in the next 5 years. As of 2022, the global Systemic Lupus Erythematosus (Sle) Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Autoimmune Drugs Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 78
    This study focuses on China's Autoimmune Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. Th......
  • Autoimmune Drugs Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 71
    This study focuses on China's Autoimmune Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of......
  • Autoimmune Drugs Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 201
    China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • Autoimmune Collaboration and Licensing Deals 2016-2023
    Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 450
    Autoimmune Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023. The report includes coverage of the following autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Infla......
  • Global Autoimmune Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Autoimmune Drugs market: According to our latest research, the global Autoimmune Drugs market looks promising in the next 5 years. As of 2022, the global Autoimmune Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Autoimmune Drugs market......
  • Global Autoimmune Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 92
    Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental ......
  • Global Systemic Lupus Erythematosus (SLE) Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 75
    SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......
  • Global Systemic Lupus Erythematosus (Sle) Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 11-Jul-2023        Price: US 3260 Onwards        Pages: 130
    The Systemic Lupus Erythematosus (Sle) Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Systemic Lupus Erythematosus (Sle) Drugs industry, and breaks down according to the type, application, and consumption area of Systemic Lupus Erythematosus (Sle) Drugs. The report also introduces players in the industry from the per......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs